Filter Articles
Research in CIDP: Are we making progress?
By Jeffrey A. Allen, MDMember, GBS|CIDP Foundation Global Medical Advisory Board CIDP as a named…
A 30th Celebration to Remember
Cheers to 30 Years! It was the best of all worlds this past November at…
Subcutaneous Immunoglobulin: A Newly Approved Treatment Option for CIDP
David Saperstein, MDCo-Director GBS/CIDP Center of ExcellencePhoenix Neurological AssociatesPhoenix, AZ Intravenous immunoglobulin (IVIg) is one…
Vaccines and Guillain Barre Syndrome 2018
Infections and vaccines have been hypothesized to play a role in triggering the development of…
2018 Research Grant Finalists Announced
Research is critical to serving the cause and the community. The GBS-CIDP Foundation International believes…
Founder Estelle Benson Named 2018 NORD Honoree for Abbey S. Meyers Leadership Award
March 21, 2018 — The National Organization for Rare Disorders (NORD) today announced the people,…
FDA approves CSL Behring treatment for CIDP
The Food and Drug Administration granted marketing clearance Friday for Hizentra, a treatment for chronic inflammatory demyelinating…
2017 GBS|CIDP Foundation Grant Awardees
(#1) Title of the project: Enhance Peripheral Nerve Repair by Modulating Macrophage Subsets Investigator: Gang Zhang, M.D;…
Research Published on Quality of Life in Inflammatory Neuropathies: the IN-Qol
In 2008 the GBS|CIDP Foundation awarded a $60,000 to Ingemar S. J. Merkies, MD, PHD…
Hansa Medical receives FDA Orphan Drug Designation for IdeS and the treatment of Guillain-Barré syndrome
February 16, 2018 Hansa Medical today announced that the U.S. Food and Drug Administration (FDA)…
Interlaken Leadership Awards
The Interlaken Leadership Awards support original research in the field of neuroimmunology. Investigators whose proposals…
Towards an affordable treatment of GBS for patients from low-income countries
Guillain-Barré syndrome (GBS) takes its toll on the resource poor developing countries where the incidence…
A dose-response trial of IV immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)/DRIP study
K. Kuitwaard1,2, E Brusse1, A.F.J.E. Vrancken4, F. Eftimov5, N.C. Notermans4, A.J. van der Kooi5, I.S.J.…
Charity Navigator Names GBS|CIDP Foundation as ‘Charity Worth Watching’
10 Charities Worth Watching Many of America's most effective charities are also household names. But…
Announcing the 2017 GBS|CIDP Foundation Grant Awardees
2017 GBS|CIDP Foundation Grant Awardees (#1) Title of the project: Enhance Peripheral Nerve Repair by Modulating Macrophage…